Regen BioPharma, Inc.
RGBP
$0.058
-$0.0034-5.54%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.40K | -515.40K | -264.90K | -130.10K | -122.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 12.60K | 12.60K | 16.00K | 4.30K | 4.30K |
| Total Other Non-Cash Items | 0.00 | 5.20K | 152.10K | 2.30K | 0.00 |
| Change in Net Operating Assets | -94.50K | 431.20K | -52.00K | -49.10K | -91.20K |
| Cash from Operations | -101.20K | -66.40K | -148.90K | -172.60K | -209.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 102.90K | 65.80K | 19.10K | -- | -- |
| Total Debt Repaid | -- | -- | 40.50K | 21.00K | -25.00K |
| Issuance of Common Stock | -- | -- | 28.10K | 135.30K | 187.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.90K | 65.80K | 87.80K | 156.30K | 162.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | 0.00 |
| Net Change in Cash | 1.60K | -600.00 | -61.10K | -16.30K | -46.40K |